Evolution management stage nonseminomatous germ-cell tumors testis sequence treatment modalities stage nonseminomatous germ-cell cancer evolution treatment past decades lymphadenectomy radiation therapy retroperitoneal lymphadenectomy nerve-sparing retroperitoneal lymphadenectomy new concept investigators patient eligibility criteria predictors response relapse Primary predictors treatment success local tumor stage status presence vascular lymphatic invasion primary tumor histology studies critical review accuracy radiologic staging past decade imperfect advent effective chemotherapy improved patient salvage relapse studies quality life issues incorporated management decisions conclusion management stage nonseminomatous germ-cell cancer one treatment patients treatment advantages disadvantages treatment therefore patient patients emphasis identification relapse risk factors meticulous pathologic review accurate radiologic patients clinical stage unfavorable prognostic factors presence vascular invasion primary tumor embryonal carcinoma tumor retroperitoneal lymphadenectomy nodes negative frozen section retroperitoneal lymphadenectomy nerve-sparing retroperitoneal lymphadenectomy bilateral retroperitoneal lymphadenectomy chance cure Patients stage favorable prognostic factors tumor teratocarcinoma absence vascular invasion primary tumor suitable surveillance nerve-sparing retroperitoneal lymphadenectomy options patient decision Future efforts field number directions fertility paramount issue patients long-term studies necessary changes semen characteristics eventual paternity patients surveillance protocols nerve-sparing modified retroperitoneal lymphadenectomy improvements chemotherapy improved efficacy reduced toxicity pathologic radiographic serologic predictors site eventual relapse importance patients significant risk distant relapse initial chemotherapy protocol ABSTRACT TRUNCATED AT WORDS 